FindTrial
Sign In

Follow-up assessment of long length Pronova-XR Drug Eluting Stent

Ideal Registry - Pronova-XR - Long stent Registry - IVUS Guided long Lesion PTCA observational Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/06/003730
Enrollment
30
Registered
2013-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient requiring to undergo PCI as treatment

Interventions

None listed

Sponsors

Vascular Concepts ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1) Age > 18 years old. 2) Lesion length > 30mm 3)One or multiple vessels of 2.50mm-4.00 mm in diameter 4) Patient with symptoms & signs of Ischemia eligible for PCI.

Exclusion criteria

Exclusion criteria: 1) Patients who have major bleeding and hematological problem 2) Patients who are noncompliant for DAPT protocol. 3)Exposure to any other investigational device or drug in the recent past 4)If there is a requirement of overlapping Stents to cover entire lesion.

Design outcomes

Primary

MeasureTime frame
1)Late Lumen Loss 2)Death Timepoint: 6 months—

Secondary

MeasureTime frame
1) MACE (Death, MI or TVF) 2) Stent Thrombosis as per ARC definition 3)Persistent Stenosis Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Shirish MS Hiremath

Ruby Hall Clinic

shirish.hiremath2011@gmail.com020-66455376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026